Levels of iGAS infections remained high up to 2 years after lifting nonpharmaceutical interventions, and this increase is undoubtedly multifactorial. Continued high-quality surveillance is required to follow up the situation.
Cornelissen et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: